Inactive Total Small Business Set-Aside (FAR 19.5)

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires SARS-CoV2 3CL protease cell-based assay development for drug screening to support e... The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires SARS-CoV2 3CL protease cell-based assay development for drug screening to support efforts related to COVID-19. This requirement includes assay development, stable cell line generation and selection by luciferase activity as outlined in the Statement of Work. See attached CSS and Statement of Work.